|
Report Date : |
03.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
GIANT & MEDCOM CORP. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
11.03.1981 |
|
|
|
|
Com. Reg. No.: |
30939019 |
|
|
|
|
Legal Form : |
Joint Stock
Company |
|
|
|
|
Line of Business : |
Import and trade
of medical products. |
|
|
|
|
No. of Employees : |
About 150
Employees(Group) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Credit Opinion: |
|
Registered Name: |
Giant & Medcom Corp. |
|
Registered Address: |
|
|
Date of Foundation: |
|
|
Registration Number: |
30939019 |
|
Registry: |
Taipei City Government |
|
Registered Capital: |
(As of 2012.8, 1 NTD = 0.03325 USD) |
|
Paid-up Capital: |
NTD 10,000,000 (USD 332,512) |
|
Legal Representatives: |
Dengbin Xiao |
|
Legal Form: |
|
|
Principal Activities: |
|
|
Staff: |
|
|
Listed
at Stock Exchange: |
|
|
Date
of Last Annual Return: |
Subject was incorporated on
Change of Name
|
Former English Name |
Giant Medical Corp. |
|
Current English Name |
Giant & Medcom Corp. |
|
Name |
Subscription Amount |
|
Dengbin Xiao |
345,100 |
|
Caizhou Jian |
|
|
50,000 |
|
|
Youwei Xiao |
50,000 |
The information above is that of subject’s major shareholders.
Related Companies
|
1 |
|
|
Name |
Universal
Integrated Corp. |
|
Address |
|
|
2 |
|
|
Name |
Chin An Trade Corporation (Translated) |
|
Address |
Room 5, 11 Floor, No.33 Sec2 Jianguo North Road,
Zhongshan District, Taipei |
|
Telephone Number |
+886-27523237 |
|
3 |
|
|
Name |
|
|
Address |
|
Core Management
|
1 |
|
|
Name |
Dengbin Xiao |
|
Position |
Board
of Chairman |
|
2 |
|
|
Name |
Caizhou
Jian |
|
Position |
Director |
|
3 |
|
|
Name |
Youwei
Xiao |
|
Position |
Director |
|
4 |
|
|
Name |
Xiuwen
Xiao |
|
Position |
Supervisor |
Personnel Structure
|
Total
Employees |
About 150
Employees(Group) |
Offices & Factories
|
|
Headquarters |
|
Add |
|
Production Information
l
Subject
is a trader of medical products and the
related products without any production activities
Purchase Information
l
The
registered activities of subject:
|
Business
Code |
Details |
|
F102040 |
Wholesale of beverage |
|
F102170 |
Wholesale of food |
|
F108021 |
Wholesale of western medicine |
|
F108031 |
Wholesale of medical devices |
|
F108040 |
Wholesale of cosmetic |
|
F203010 |
Retail of food and beverage |
|
F208021 |
Retail of western medicine |
|
F208031 |
Retail of medical devices |
|
F208040 |
Retail of cosmetic |
|
F401010 |
International trade |
|
ZZ99999 |
Besides licensed business, all other
business items those are not banned or restricted. |
l
The
productions are mostly purchased from abroad.
Sales Information
l
Subject
is mainly engaged in trading of healthcare products and the related products.
l
Subject
introduced that it
l
Subject
introduced some brands it trades, such as Xanthium, Erispan, Salagen, Fleet,
Dermatix, Glyquin, Eve and so on.
l
Subject
introduced that its products are mainly imported from abroad, such as Japan,
USA, Europe and so on.
l
Subject
introduced that its customers include hospitals, clinics, and supermarkets,
etc.
l
Subject
introduced that it sells products to the domestic market.
Import and export right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Subject declined to disclose the purchase settlements information, and from other sources, we couldn’t obtain the information, either.
Sales
Domestic
Markets (Taiwan)
|
Sales Terms |
Proportion |
|
|
|
COB, CBD, etc |
100% |
Export
Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.
Subject’s relevant staff Mr. Qiu declined to disclose its financials citing the grounds of company’s confidentiality; from other source we can not obtain the relevant information, either.
The bankers’
information is not available from the subject or other sources.
Mortgage
No chattel mortgage
record of subject has been found within the recent 3 months.
Lawsuit
Up to date of reporting, no existing or
latent litigation of the subject has been found.
|
Name |
|
|
Position: |
Salesman |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.78 |
|
UK Pound |
1 |
Rs.86.75 |
|
Euro |
1 |
Rs.68.32 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.